Prosecution Insights
Last updated: April 19, 2026
Application No. 18/300,010

Low Cost Syringe with Durable and Disposable Components

Non-Final OA §102§112
Filed
Apr 13, 2023
Examiner
OSINSKI, BRADLEY JAMES
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
BECTON, DICKINSON AND COMPANY
OA Round
1 (Non-Final)
79%
Grant Probability
Favorable
1-2
OA Rounds
3y 6m
To Grant
90%
With Interview

Examiner Intelligence

Grants 79% — above average
79%
Career Allow Rate
922 granted / 1173 resolved
+8.6% vs TC avg
Moderate +11% lift
Without
With
+11.1%
Interview Lift
resolved cases with interview
Typical timeline
3y 6m
Avg Prosecution
46 currently pending
Career history
1219
Total Applications
across all art units

Statute-Specific Performance

§101
0.6%
-39.4% vs TC avg
§103
45.7%
+5.7% vs TC avg
§102
24.5%
-15.5% vs TC avg
§112
18.0%
-22.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1173 resolved cases

Office Action

§102 §112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant's election with traverse of Group I in the reply filed on 2/23/2026 is acknowledged. The traversal is on the ground(s) that the examiner has not provided sufficient evidence to support the conclusion that the subcombination has separate utility and thus not distinct. This is not found persuasive because the devices of the subcombinations are comprised of a single element of each structure, while the combination includes a plurality of some of the structures, resulting in a smaller device (and thus the required packaging size). The requirement is still deemed proper and is therefore made FINAL. Claim Objections Claim 5 is objected to because of the following informalities: “wherein a proximal portion of the disposable tubular insert has a proximal portion of the reusable outer sleeve are each formed....” does not make sense. It is assumed the “has” should be “and”. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claim 12 is rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. In claim 12, it is unclear how a reusable outer sleeve is related to that in claim 1. Further, claim 12 has “a disposable insert” and seems to be claimed separately from “a disposable tubular insert” in claim 1, yet it is unclear how they are separate and based upon the specification seem to be the same. Claim Rejections - 35 USC § 102 (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 7 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Lloyd et al (US 8,038,656). Regarding claim 7, Lloyd discloses a syringe comprising: a disposable portion comprising a fluid reservoir 110 having a fluid opening (in end 110b) at a distal end thereof and a stopper 130 movably received in the fluid reservoir for sealing a proximal end of the fluid reservoir (fig 8 vs fig 13) and for displacing fluid into or out of the fluid reservoir through the fluid opening upon movement of the stopper within the fluid reservoir (as it is moved proximally and distally); and a reusable portion 120 comprising a user-operable plunger detachably coupled to the stopper (title; Col.1 ll 45-48) for causing the stopper to move within the fluid reservoir and thereby displace fluid into or out of the fluid reservoir through the fluid passage under the control of the user (Col.4 ll 22-26). Allowable Subject Matter Claims 1-6, 8-11 and 13 are allowed. The closest art is considered Loe (US 2008/0086092) in view of Taranto et al (US 5,651,774). Loe teaches everything except the visible scale on the reusable outer sleeve and the threaded collar engaging by movement from a distal position to a proximal position. Taranato is a suggestion to place the visible scale on the outer sleeve. As to the remaining limitation, Loe teaches engagement with the tubular insert via a tightening of the collar from a proximal position to a distal position, the opposite that claimed, and modifying Loe to reach the claimed limitation would be based on impermissible hindsight. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to BRADLEY JAMES OSINSKI whose telephone number is (571)270-3640. The examiner can normally be reached Monday to Thursday 9AM to 5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Michael Tsai can be reached at (571)270-5246. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /BRADLEY J OSINSKI/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Apr 13, 2023
Application Filed
Mar 02, 2026
Non-Final Rejection — §102, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12594373
A PACKAGE ASSEMBLY
2y 5m to grant Granted Apr 07, 2026
Patent 12594412
FLUSH SYRINGE WITH MULTIPLE SCRUBBING DEVICES
2y 5m to grant Granted Apr 07, 2026
Patent 12597499
TRANSMISSION OF DATA ASSOCIATED WITH AN INJECTION DEVICE USAGE USING PASSIVE RF MODULATION
2y 5m to grant Granted Apr 07, 2026
Patent 12582810
DELIVERY DEVICE FOR ORAL DELIVERY OF DRUG SUBSTANCES
2y 5m to grant Granted Mar 24, 2026
Patent 12576253
Drug Delivery Device with Intravesical Tolerability
2y 5m to grant Granted Mar 17, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
79%
Grant Probability
90%
With Interview (+11.1%)
3y 6m
Median Time to Grant
Low
PTA Risk
Based on 1173 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month